A Novel CLN1 Variant in a Turkish Patient with Infantile Neuronal Ceroid Lipofuscinoses
PDF
Cite
Share
Request
Case Report
E-PUB
12 May 2026

A Novel CLN1 Variant in a Turkish Patient with Infantile Neuronal Ceroid Lipofuscinoses

Inherit Metab Disord Nutr. Published online 12 May 2026.
1. İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Metabolism and Nutrition, İstanbul, Türkiye
2. Harran University Faculty of Medicine, Department of Metabolism and Nutrition, Şanlıurfa, Türkiye
3. Intergen Genetics and Rare Diseases Diagnosis Research and Application Center, Ankara, Türkiye
No information available.
No information available
Received Date: 22.12.2025
Accepted Date: 24.03.2026
E-Pub Date: 12.05.2026
PDF
Cite
Share
Request

ABSTRACT

The neuronal ceroid lipofuscinoses (NCLs) are a group of progressive neurodegenerative disorders characterised by abnormal accumulation of ceroid and lipofuscin in lysosomes and the cytoplasm. The progressive accumulation of ceroid and lipofuscin in the central nervous system leads to psychomotor retardation, vision loss, and epilepsy. NCLs are the most common neurodegenerative diseases of childhood, and a diagnosis of NCLs should be considered in individuals presenting with characteristic clinical symptoms and magnetic resonance imaging findings. A definitive diagnosis should be confirmed by an enzyme activity assay, skin biopsy or variant analysis. We present a case of infantile NCL with a novel variant.

Keywords:
CLN1, Infantile neuronal ceroid lipofuscinoses, Novel variant